glp 1 patches drug interactions Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor Agonists through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem Designing GLP-1 delivery: structural perspectives
Description
2018 Apr 3;27(4):740-756
For example, in a patient with intentional overdose who is also on a GLP-1 agonist, the time to peak concentration of co-ingested agents may be prolonged, complicating risk assessment, decontamination decisions, and timing of antidotal therapies
Efficacy and safety of onceweekly dulaglutide versus insulin glargine in patients with type 2 diabetes on metformin and glimepiride (AWARD2)
The role of pancreatic preproglucagon in glucose homeostasis in mice
Cramon, L
Gamboa, J.L
